Winner Medical(SZ:300888) Zhong Guo Jing Ji Wang·2025-09-17 06:27Core Points - The company,稳健医疗, announced the listing of previously issued shares on September 12, with a total share capital of 582,329,808 shares, of which 407,246,427 shares are subject to restrictions, accounting for 69.93% of the total share capital [1] - The restricted shares to be listed amount to 406,614,387 shares, representing 69.8254% of the total share capital, with the listing date set for September 17, 2025 [1] - The sole shareholder applying for the lifting of restrictions is the controlling shareholder, 稳健集团有限公司, which has complied with all commitments made since the company's listing [2] Financial Summary - The company was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on September 17, 2020, with an initial issuance of 50 million shares at a price of 74.30 yuan per share [2] - The total funds raised amounted to 3.715 billion yuan, with a net amount of 3.559 billion yuan after deducting issuance costs, exceeding the original plan by 2.133 billion yuan [2] - The funds were intended for projects including high-end dressing production line construction, marketing network development, research center establishment, and digital management system implementation [2] Underwriting and Dividend Information - The underwriting institution for the listing is China International Capital Corporation, with underwriting fees totaling 156 million yuan, of which 123 million yuan is allocated to the underwriting institution [3] - In the 2022 annual equity distribution announcement, the company proposed a cash dividend of 19.00 yuan (tax included) for every 10 shares, along with a capital increase of 4 shares for every 10 shares held [3]